Earlier treatment of nmdar antibody encephalitis in children results in a better outcome

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 4, 2015, Pages 1-3

  Byrne, Susan ^a,b   Walsh, Cathal ^c   Hacohen, Yael ^d   Muscal, Eyal ^e   Jankovic, Joseph ^e   Stocco, Amber ^e   Dale, Russell C ^f,g   Vincent, Angela ^c   Lim, Ming ^a,c   King, Mary ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHILDREN S UNIVERSITY HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF SYDNEY   (Australia)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE; STEROID;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; CHILD; EARLY CHILDHOOD INTERVENTION; FOLLOW UP; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; ONSET AGE; PRIORITY JOURNAL; RANKIN SCALE; TREATMENT OUTCOME;

EID: 85020399458     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000130     Document Type: Article

References (7)

1. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12:157-165.
2. Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133:1655-1667.
3. Moscato EH, Peng X, Jain A, Parsons TD, Dalmau J, Balice-Gordon RJ. Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2014; 76:108-119.
4. Mikasova L, De Rossi P, Bouchet D, et al. Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. Brain 2012; 135:1606-1621.
5. Finke C, Kopp UA, Scheel M, et al. Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 2013; 74:284-296.
6. Zandi MS, Paterson RW, Ellul MA, et al. Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry. Epub 2014 Sep 22. doi:10.1136/jnnp-2014-308736.
7. Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13:167-177.